Status: Recruiting
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
This feasibility study will be conducted to demonstrate the initial safety and effectiveness of the CellFX® nsPFA™ Cardiac Clamp in performing a box lesion around the 4 pulmonary veins as an isolated procedure or as a part of a more extensive surgical ablation set in conjunction with concomitant cardiac surgical procedure.
Participants needed: 30
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Pulse Biosciences, Inc.Updated: Jan 12, 2026Locations: 6
Eligibility criteria
Subject must be between 18 and 85 years of age [+5]
Subject has an implantable electronic medical device. (i.e., pacemaker, ICD or C... [+29]